ANIP — ANI Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual balance sheet for ANI Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	7.86	100	48.2	221	151
Net Total Accounts Receivable
Net Total Receivables	95.8	132	169	162	222
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	170	322	344	520	528
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	41.3	52.7	43.2	44.6	56.9
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	461	772	760	904	1,284
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	78.6	87.5	99.4	145	194
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	265	413	422	447	855
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	196	359	339	458	429
Total Liabilities & Shareholders' Equity	461	772	760	904	1,284
Total Common Shares Outstanding
Total Preferred Shares Outstanding